| Ms Terrie D Baker, LVN | |
|
1800 Fm 1092 Rd Apt 1208, Missouri City, TX 77459-1608 | |
| (409) 998-9857 | |
| Not Available |
| Full Name | Ms Terrie D Baker |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 1800 Fm 1092 Rd Apt 1208, Missouri City, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962985515 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 194380 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Terrie D Baker, LVN 1800 Fm 1092 Rd Apt 1208, Missouri City, TX 77459-1608 Ph: (409) 998-9857 | Ms Terrie D Baker, LVN 1800 Fm 1092 Rd Apt 1208, Missouri City, TX 77459-1608 Ph: (409) 998-9857 |
News Archive
Par Pharmaceutical Companies, Inc. today announced that it has begun shipping all four strengths of amlodipine and valsartan tablets, the generic version of Novartis' Exforge. Par received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for amlodipine and valsartan and was granted 180 days of marketing exclusivity.
Doctors may be able to tailor a specialized form of brain surgery to more closely match the needs of Parkinson patients, according to results from the first large-scale effort to compare the two current target areas of deep brain stimulation surgery, or DBS.
NephroGenex, Inc., a privately held drug development company focusing on kidney disease, today announced the completion of patient enrollment in its Phase 2b clinical trial (PYR-210) studying the safety and efficacy of its lead drug candidate Pyridorin (pyridoxamine dihydrochloride) in type 2 diabetic patients with overt diabetic nephropathy. Three hundred and seventeen (317) patients have been randomized.
Parkinson's disease is a degenerative disorder of the central nervous system that is characterized by tremors, rigidity, slowness of movement, and difficulty walking. It is caused by loss of the neurons that produce the neurotransmitter dopamine (known as dopaminergic neurons). One of the primary goals in Parkinson's disease research is to develop a replacement for dopaminergic neurons.
On July 26, 2011, Mark Zaurov, a deaf Ph.D. candidate at the University of Hamburg, Germany who had recently completed a four-month fellowship at the US Holocaust Memorial Museum in Washington, presented "Deaf Holocaust." His research includes interviews with Deaf Holocaust survivors and Deaf German perpetrators.
› Verified 3 days ago
Milka Njeri Adewuyi, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 4502 Riverstone Blvd Ste 905, Missouri City, TX 77459 Phone: 281-903-7613 Fax: 832-532-7504 | |
Abubakarr Kallon, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 6643 Mccullum Rd, Missouri City, TX 77489 Phone: 832-366-6730 | |
Ms. Barbara G Lawyer, NURSE-1972 Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 17131 Quail Park Dr, Missouri City, TX 77489 Phone: 281-416-4666 Fax: 281-416-4666 | |
Sakina Underwood, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 4502 Riverstone Blvd Ste 905, Missouri City, TX 77459 Phone: 281-903-7613 Fax: 832-532-7504 | |
Mrs. Oyinlola Bolanle Oshiokhale, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 4502 Riverstone Blvd, Missouri City, TX 77459 Phone: 281-903-7613 | |
Peace Kemirembe, LVN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 4502 Riverstone Blvd, Missouri City, TX 77459 Phone: 281-903-7613 | |
Christiana Chizoba Okeke, LVN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 4502 Riverstone Blvd, Missouri City, TX 77459 Phone: 832-382-3935 |